Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,766.40
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.29
(
6.60%
)
Bitcoin
71,265.40
(
-3.62%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 102233

Tuesday, 08/24/2010 9:33:23 AM

Tuesday, August 24, 2010 9:33:23 AM

Post# of 257257

Most, if not all, new efficacy trials of HCV drugs will likely have to stratify trial arms according to IL-28B variants.




Case in point from todays PR from VRUS:


Patients will be stratified by IL28B status to ensure balance across cohorts.

“I am a big believer in giving it all away and have always said that the best financial planning ends with bouncing the check to the undertaker.”


Mike Bloomberg

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now